Margaret G Mcglynn Amicus Therapeutics, Inc. (FOLD) insider trading activity

Margaret G Mcglynn is of AMICUS THERAPEUTICS, INC.. Currently has a direct ownership of 71,136 shares of FOLD, which is worth approximately $712,782. The most recent transaction as insider was on Jun 06, 2024, when has been sold 11,847 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 71.1K

19.98% 3M change

19.98% 12M change

Total Value Held $712,782

MARGARET G MCGLYNN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 06 2024	BUY Grant, award, or other acquisition	-	11,847 Added 14.28%	71,136 Common Stock
Mar 05 2024	SELL Open market or private sale	$100,500 $13.4 p/Share	7,500 Reduced 11.23%	59,289 Common Stock
Mar 05 2024	BUY Exercise of conversion of derivative security	$21,000 $2.8 p/Share	7,500 Added 10.1%	66,789 Common Stock
Mar 04 2024	SELL Open market or private sale	$99,675 $13.29 p/Share	7,500 Reduced 11.23%	59,289 Common Stock
Mar 04 2024	BUY Exercise of conversion of derivative security	$21,000 $2.8 p/Share	7,500 Added 10.1%	66,789 Common Stock
Jun 08 2023	BUY Grant, award, or other acquisition	-	8,584 Added 12.65%	59,289 Common Stock
Jan 13 2023	SELL Open market or private sale	$195,450 $13.03 p/Share	15,000 Reduced 22.83%	50,705 Common Stock

Jan 13 2023	BUY Exercise of conversion of derivative security	$49,800 $3.32 p/Share	15,000 Added 18.59%	65,705 Common Stock
Jun 09 2022	BUY Grant, award, or other acquisition	-	12,671 Added 19.99%	50,705 Common Stock
May 02 2022	SELL Open market or private sale	$104,850 $6.99 p/Share	15,000 Reduced 28.28%	38,034 Common Stock
May 02 2022	BUY Exercise of conversion of derivative security	$71,850 $4.79 p/Share	15,000 Added 22.05%	53,034 Common Stock
Jun 10 2021	BUY Grant, award, or other acquisition	-	10,115 Added 21.01%	38,034 Common Stock
May 03 2021	SELL Open market or private sale	$102,700 $10.27 p/Share	10,000 Reduced 26.37%	27,919 Common Stock
May 03 2021	BUY Exercise of conversion of derivative security	$75,100 $7.51 p/Share	10,000 Added 20.87%	37,919 Common Stock

Also insider at

APD

Air Products & Chemicals, Inc. Basic Materials

Director

NVAX

NOVAVAX INC Healthcare

VRTX

VERTEX PHARMACEUTICALS INC Healthcare

Director

MGM